|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.790 SEK | +2.21% |
|
+5.90% | -34.89% |
| 07-07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 07-01 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 97.32M 9.96M 8.76M 8.14M 7.48M 14.04M 965M 14.29M 37.96M 470M 37.39M 36.59M 1.63B | P/E 2026 * |
-2.87x | P/E 2027 * | -2.1x |
|---|---|---|---|---|---|
| Enterprise Value | 89.32M 9.14M 8.04M 7.47M 6.87M 12.88M 885M 13.11M 34.84M 432M 34.32M 33.58M 1.5B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | +2.21% | ||
| 1 week | +5.90% | ||
| Current month | +3.41% | ||
| 1 month | -1.12% | ||
| 3 months | +11.27% | ||
| 6 months | -20.09% | ||
| Current year | -34.89% |
| 1 week | 7.6 |  | 8.9 |
| 1 month | 7.6 | | 9.18 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 319 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 2023-01-22 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 2026-06-30 |
| Chief Tech/Sci/R&D Officer | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 2022-05-24 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 2019-09-25 |
Pål Ryfors
BRD | Director/Board Member | 43 | 2022-05-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/25/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 3/24/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 12/20/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | +5.90% | -61.70% | -66.19% | 9.83M | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.60% | +0.69% | +17.92% | +38.47% | 355.74B | |
| Weighted average by Cap. | +1.73% | +1.17% | +35.87% | +75.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.17M -2.79M -2.59M -2.38M -4.47M -307M -4.55M -12.09M -150M -11.91M -11.65M -520M | -46M -4.71M -4.14M -3.85M -3.54M -6.63M -456M -6.75M -17.94M -222M -17.68M -17.29M -772M |
| Net Debt | -8M -819K -720K -669K -615K -1.15M -79.3M -1.17M -3.12M -38.68M -3.07M -3.01M -134M | -10M -1.02M -900K -836K -769K -1.44M -99.12M -1.47M -3.9M -48.35M -3.84M -3.76M -168M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | SEK 8.790 | +2.21% | 4,329 |
| 26-07-22 | SEK 8.600 | -2.05% | 3,443 |
| 26-07-21 | SEK 8.780 | -0.23% | 2,492 |
| 26-07-20 | SEK 8.800 | +5.64% | 7,091 |
| 26-07-17 | SEK 8.330 | -5.34% | 7,339 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
